Computerized cognitive behavioral therapy with sertraline in schizophrenia with depressive episodes: A 12-week randomized controlled trial

Table 2 Sociodemographic and clinical data

Characteristic	All patients (n = 68)	Experimental group (n = 34)	Control group (n = 34)	P value
Age, mean ± SD, years	36.54 ± 9.96	36.18 ± 9.33	36.91 ± 10.68	0.763
Gender, n (%)				0.806
Male	39 (57.4)	19 (55.9)	20 (58.8)
Female	29 (42.6)	15 (44.1)	14 (41.2)
Year of education, mean ± SD, years	10.50 ± 2.64	10.32 ± 2.78	10.68 ± 2.52	0.585
Marital status, n (%)				0.314
Single	42 (61.8)	20 (58.8)	22 (64.7)
Married	18 (26.5)	8 (23.5)	10 (29.4)
Divorced	8 (11.8)	6 (17.6)	2 (5.9)
Family history, n (%)	12 (17.6)	6 (17.6)	6 (17.6)	1.000
Disease duration, mean ± SD, years	13.62 ± 6.44	13.52 ± 6.42	13.72 ± 6.57	0.902
Sertraline dosage at 4 weeks, median (IQR), mg	150 (100-150)	150 (100-150)	150 (100-150)	0.509
Sertraline dosage at 12 weeks, median (IQR), mg	150 (100-150)	150 (100-150)	150 (100-150)	0.314